CytoDyn Investor Relations Material
Latest events
AGM 2024
CytoDyn
Q4 2025
25 Jul, 2025
Q3 2025
14 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CytoDyn Inc
Access all reports
CytoDyn Inc. is a biotechnology company focused on the development of innovative treatments for infectious diseases, cancer, and immune-related conditions. The company specializes in monoclonal antibody therapies and explores applications in virology, immunology, and oncology. The company is headquartered in Vancouver, Washington, and its shares are listed on the OTCQB.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
CYDY
Country
🇺🇸 United States